RAB39A and cancer: The RAB39A‒RXRB axis drives cancer stemness and tumorigenesis; consequently, the downregulation of this pathway leads to poor sphere formation and xenotransplantable function in several types of malignancies, such as sarcomas, adrenal, lymphoid, and testicular tumors [71].